CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.87B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.13: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.58%Below 5Y avg (1.11%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
104.2%High
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
26.01BCNY3.87B · vs all stocks (USD)
Trailing P/E
71.21xRevenue (TTM)
8.55BCNY1.27B · vs all stocks (USD)
Profit Margin
4.36%Beta
0.1330xvs all stocks
52-Week Change
-22.90%vs all stocks
Market Capitalization
26.01BCNY3.87B · vs all stocks (USD)
Enterprise Value
32.17BCNY4.78B · vs all stocks (USD)
Trailing P/E
71.21xForward P/E
51.79xPrice to Sales (TTM)
2.99xPrice to Book (MRQ)
2.65xEnterprise to Revenue
3.76xEnterprise to EBITDA
21.90xGross Margin
57.67%Profit Margin
4.36%Operating Margin
13.20%Return on Assets (TTM)
1.39%Return on Equity (TTM)
3.34%Revenue (TTM)
8.55BCNY1.27B · vs all stocks (USD)
Revenue per Share (TTM)
5.70CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-1.40%Gross Profit (TTM)
4.81BCNY715.70M · vs all stocks (USD)
EBITDA (TTM)
1.31BCNY194.51M · vs all stocks (USD)
Net Income (TTM)
373.17MCNY55.49M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
35.90%Operating Cash Flow (TTM)
1.43BCNY213.19M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.12BCNY-166.33M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.58%vs all stocks
5-Year Average Dividend Yield
1.11%vs all stocks
Payout Ratio
104.17%Minority Interest (Equity)
13.35MCNYFY2025 · Dec 31, 2025Revenue
8.59BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.42BCNYFY2025 · Dec 31, 2025Gross Profit
5.17BCNYFY2025 · Dec 31, 2025Operating Income
833.51MCNY123.95M · vs all stocks (USD)
Pre-tax Income
443.88MCNYFY2025 · Dec 31, 2025Income Tax Expense
216.55MCNYFY2025 · Dec 31, 2025Net Income
227.33MCNYFY2025 · Dec 31, 2025EBIT
677.48MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.84BCNYFY2025 · Dec 31, 2025Research & Development
1.23BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
2.11BCNYFY2025 · Dec 31, 2025Other Operating Expenses
111.13MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
25.83MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
233.60MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.48BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.48BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
227.33MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
39.07MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-95.18MCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.05BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.45BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
227.33MCNYFY2025 · Dec 31, 2025Other Non-cash Items
280.54MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-126.34MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-476.71MCNYFY2025 · Dec 31, 2025Capital Expenditures
-1.96BCNYFY2025 · Dec 31, 2025Purchase of Investments
-30.00MCNYFY2025 · Dec 31, 2025Sale of Investments
118.54MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.87BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
4.73BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-4.30BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-546.18MCNYFY2025 · Dec 31, 2025Other Financing Charges
753.13MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
628.94MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.50BSharesUpdated Aug 20, 2026Float Shares
883.26MSharesUpdated Aug 20, 2026% Held by Insiders
42.57%vs all stocks
% Held by Institutions
5.06%vs all stocks
Total Cash (MRQ)
1.97BCNY293.66M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.32CNYUpdated Aug 20, 2026Total Debt (MRQ)
8.67BCNY1.29B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8798xCurrent Ratio (MRQ)
1.01xBook Value per Share (MRQ)
6.45CNYUpdated Aug 20, 2026Total Assets
21.50BCNY3.20B · vs all stocks (USD)
Total Current Assets
8.74BCNYFY2025 · Dec 31, 2025Total Liabilities
12.05BCNYFY2025 · Dec 31, 2025Total Non-current Assets
12.76BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.93BCNYFY2025 · Dec 31, 2025Total Current Liabilities
9.11BCNYFY2025 · Dec 31, 2025Cash
1.47BCNYFY2025 · Dec 31, 2025Cash Equivalents
37.62MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.50BCNYFY2025 · Dec 31, 2025Other Short-term Investments
75.98MCNYFY2025 · Dec 31, 2025Accounts Receivable
2.87BCNYFY2025 · Dec 31, 2025Inventory
3.71BCNYFY2025 · Dec 31, 2025Accounts Payable
1.81BCNYFY2025 · Dec 31, 2025Short-term Debt
6.12BCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.10MCNYFY2025 · Dec 31, 2025Long-term Debt
1.92BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
146.65MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.50BCNYFY2025 · Dec 31, 2025Retained Earnings
5.44BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.46BCNY1.41B · vs all stocks (USD)
Treasury Stock
100.01MCNYFY2025 · Dec 31, 202552-Week Low
13.73CNYUpdated Aug 20, 202652-Week High
27.97CNYUpdated Aug 20, 202652-Week Change
-22.90%vs all stocks
Beta
0.1330xvs all stocks
50-Day MA
16.01CNYUpdated Aug 20, 2026200-Day MA
16.45CNYUpdated Aug 20, 2026Avg 10-Day Volume
48.66MSharesUpdated Aug 20, 2026Avg 30-Day Volume
47.47MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.2400CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.58Profit Margin: 0.04
Financial Health
Altman Z-Score 2.13: grey zoneSignificant
Altman Z-Score: 2.13
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.87B, above the global median of $1.18BNotable
Market cap (USD): 3,867,541,217.469Global Median: 1,179,398,897.704
Revenue is $1.27B, above the global median of $534.05MNotable
Revenue (USD): 1,272,061,133.292Global Median: 534,052,387.958
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Duality Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Catalyst Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Arcus Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Apeloa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiamen Amoytop Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Irhythm Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Livzon Pharmaceutical Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Denali Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Viking Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule